Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2011 4
2012 4
2013 4
2014 6
2015 8
2016 2
2017 1
2018 7
2019 5
2020 6
2021 5
2022 7
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
People who inject drugs in Bangladesh - The untold burden!
Khan SI, Reza MM, Crowe SM, Rahman M, Hellard M, Sarker MS, Chowdhury EI, Rana AKMM, Sacks-Davis R, Banu S, Ross AG. Khan SI, et al. Among authors: sacks davis r. Int J Infect Dis. 2019 Jun;83:109-115. doi: 10.1016/j.ijid.2019.03.009. Epub 2019 Mar 27. Int J Infect Dis. 2019. PMID: 30928433 Free article. Review.
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, McNaughton AL, Trickey A, Ward Z, Abramovitz D, Alary M, Astemborski J, Bruneau J, Clipman SJ, Coffin CS, Croxford S, DeBeck K, Emanuel E, Hayashi K, Hermez JG, Low-Beer D, Luhmann N, Macphail G, Maher L, Palmateer NE, Patel EU, Sacks-Davis R, Van Den Boom W, van Santen DK, Walker JG, Hickman M, Vickerman P; HIV and HCV Incidence Review Collaborative Group. Artenie A, et al. Among authors: sacks davis r. Lancet Gastroenterol Hepatol. 2023 Jun;8(6):533-552. doi: 10.1016/S2468-1253(23)00018-3. Epub 2023 Mar 27. Lancet Gastroenterol Hepatol. 2023. PMID: 36996853 Free PMC article.
Pathways to the elimination of hepatitis C: prioritising access for all.
Pedrana AE, Sacks-Davis R, Doyle JS, Hellard ME. Pedrana AE, et al. Among authors: sacks davis r. Expert Rev Clin Pharmacol. 2017 Oct;10(10):1023-1026. doi: 10.1080/17512433.2017.1383894. Expert Rev Clin Pharmacol. 2017. PMID: 28942660 No abstract available.
Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis.
Koopsen J, Matthews G, Rockstroh J, Applegate TL, Bhagani S, Rauch A, Grebely J, Sacks-Davis R, Ingiliz P, Boesecke C, Rebers S, Feld J, Bruneau J, Martinello M, Hellard M, Dore GJ, Schinkel J, van der Valk M; REACT Study Group. Koopsen J, et al. Among authors: sacks davis r. Lancet Microbe. 2023 Aug;4(8):e622-e631. doi: 10.1016/S2666-5247(23)00108-8. Epub 2023 Jun 16. Lancet Microbe. 2023. PMID: 37336226 Free article.
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies.
Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration. Sacks-Davis R, et al. Lancet HIV. 2024 Feb;11(2):e106-e116. doi: 10.1016/S2352-3018(23)00267-9. Epub 2024 Jan 12. Lancet HIV. 2024. PMID: 38224708
71 results